Mitral Valve Disease Market Size, Share, Trends, Growth and Forecast 2032

Mitral Valve Disease Industry Prospective:

The global mitral valve disease market size was evaluated at $3.7 billion in 2023 and is slated to hit $7.7 billion by the end of 2032 with a CAGR of nearly 8% between 2024 and 2032.

Request Free Sample

Mitral Valve Disease Market: Overview

Mitral valve is one of the four heart valves and regulates the flow of blood between two of the left heart chambers, namely, the left ventricle and left atrium. Moreover, mitral valve ailment occurs when mitral valve function is improper.

For the record, mitral stenosis and mitral regurgitation are some of the few kinds of mitral valve diseases. Some of the major causes of mitral valve disease include rheumatic fever, heart defects, infective endocarditis, myxomatous degeneration, and infective endocarditis.

Key Insights

• As per the analysis shared by our research analyst, the global mitral valve disease market is projected to expand annually at the annual growth rate of around 8% over the forecast timespan (2024-2032)
• In terms of revenue, the global mitral valve disease market size was evaluated at nearly $3.7 billion in 2023 and is expected to reach $7.7 billion by 2032.
• The global mitral valve disease market is anticipated to grow rapidly over the forecast timeline owing to the need for early diagnosis of the disease and demand for advanced diagnostic methods such as cardiac CT scans and echocardiography for quick detection of mitral valve ailment.
• In terms of treatment type, the mitral valve repair segment is slated to register the highest CAGR over the forecast period.
• Based on indication, the mitral regurgitation segment is predicted to contribute majorly towards global industry surge in the ensuing years.
• On the basis of end-user, the hospitals segment is likely to maintain segmental domination in the forthcoming years.
• Region-wise, the Asia-Pacific mitral valve disease industry is projected to register the fastest CAGR during the assessment timespan.

Mitral Valve Disease Market: Growth Factors

An increment in cases of heart ailments in geriatric persons will augment the global market expansion by 2032

Rising incidences of heart disorders witnessed in the aging & obese population along with inactive lifestyles as well as intake of non-nutritive food have translated into massive growth of the global mitral valve disease market.

Furthermore, breakthroughs in medical technology, along with the growing demand for minimally invasive methods, will promulgate the growth of the global market.

In addition, the need for early diagnosis of the disease and the demand for advanced diagnostic methods such as cardiac CT scans and echocardiography for quick detection of mitral valve ailment will boost the global market trends. Favorable laws and compensation policies will steer the market growth across the globe.

Mitral Valve Disease Market: Restraints

Massive increase in medical treatment costs can obstruct the growth of the global industry

Surging costs of disease treatment and the complexity of surgical methods will retard the growth of the global mitral valve disease industry. Moreover, the scarcity of skilled persons and the risks of getting infected by hospital-acquired ailments can prevent patients from opting for surgical treatments, thereby impeding global industry growth.

Mitral Valve Disease Market: Opportunities

An increase in investments in research projects will help the global market progress by leaps & bounds in the coming years

A rise in the fund allocation in research & development activities and rising patient awareness about good heart health will multiply the rate of growth of the global mitral valve disease market. Furthermore, the growing rate of screening & diagnosing patients for mitral valve disease, along with an increase in educational initiatives focused on improving patient awareness about the disease, will help in the creation of a strong base for the growth of the market.

Mitral Valve Disease Market: Challenges

Stringent legislation pertaining to approval of medical devices can challenge the global industry over forecast period

Strict laws related to the approval of new medical equipment and medicines for disease treatment are likely to challenge the global mitral valve disease industry's progress. In addition, the lack of disease treatment availability in third-world economies can deter the industry's global expansion.       

Mitral Valve Disease Market: Report Scope

Mitral Valve Disease Market: Segmentation

The global mitral valve disease market is divided into treatment type, indication, end-user, and region.

In terms of treatment type, the mitral valve disease market across the globe is segmented into mitral valve repair, mitral valve therapeutics, mitral valve replacement, and cardiac resynchronization therapy segments. Apparently, the mitral valve repair segment, which garnered nearly 55% of the global market earnings in 2023, is set to record the fastest CAGR in the next couple of years owing to breakthroughs in minimally invasive procedures and the need for maintaining heart functions along with growing demand for repair over the replacement of the valve.

Based on the indication, the global mitral valve disease industry is divided into mitral valve prolapse, mitral valve regurgitation, and mitral valve stenosis segments. Apparently, the mitral valve regurgitation segment, which led the global industry share in 2023, is set to contribute notably towards the global industry surge in the ensuing years. This can be subject to the growing occurrence of mitral valve regurgitation in comparison to other kinds of mitral valve disease. Moreover, growing awareness about health conditions and the availability of medical treatment alternatives will spur the segmental surge.

On the basis of end-user, the global mitral valve disease market is segregated into ambulatory surgical centers, hospitals, and clinics segments. Moreover, the hospital segment, which led the segmental growth in 2023, is likely to retain its segmental dominance even in the ensuing years owing to the ability of hospitals to offer post-operative patient care such as rehabilitation services and intensive care. Moreover, hospitals have doctors, infrastructure, and staff for performing complex surgeries such as open heart surgeries and minimally invasive methods such as TMVR and TAVR.

Mitral Valve Disease Market: Regional Insights

North America is likely to maintain leading status in the global market over the projected timeline

North America, which accounted for about two-thirds of the global mitral valve disease market size in 2023, is slated to establish a stronghold in the global market during the forecast timespan.

Additionally, the regional market expansion in the coming seven years can be due to presence of strong healthcare infrastructure and medical facilities in the countries such as Canada and the U.S. Moreover, an increase in the frequency of heart disorders and early diagnoses & treatment of the disease in the region will promote the market upsurge in North America.    

Asia-Pacific mitral valve disease industry is anticipated to register the highest CAGR in the expected timeline. The exponential progression of the industry in APAC can be credited to the availability of adequate medical insurance coverage that can help patients avail themselves of advanced health treatments.

Apart from this, a rise in the elderly populace prone to the ailment, along with surging healthcare spending in countries such as India and China, will multiply the growth of the industry in the region. Escalating awareness about health disorders in the region will spike the industry growth in APAC.

Mitral Valve Disease Market: Competitive Space

The global mitral valve disease market profiles key players such as:

• Artivion Inc.
• Boston Scientific Corporation
• Corcym UK Limited
• 4C Medical Technologies
• Edwards Lifesciences Corporation
• Bayer AG
• Abbott Laboratories
• Valcare Medical
• Medtronic plc
• LivaNova PLC
• Zydus Lifesciences Limited
• Pfizer Inc.
• JenaValve Technology Inc.
• ShockWave Medical Inc.
• Novartis AG
• CryoLife Inc.
• Braile Biomedica.

The global mitral valve disease market is segmented as follows:

By Treatment Type

• Mitral Valve Repair
• Mitral Valve Therapeutics
• Mitral Valve Replacement
• Cardiac Resynchronization Therapy

By Indication

• Mitral Valve Prolapse
• Mitral Regurgitation
• Mitral Stenosis

By End-User

• Ambulatory Surgical Centers
• Hospitals
• Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa